- Home
- FSTR vs LRMR Comparison
FSTR vs LRMR Comparison
Compare FSTR & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- LRMR
- Stock Information
- Founded
- FSTR 1902
- LRMR N/A
- Country
- FSTR United States
- LRMR United States
- Employees
- FSTR N/A
- LRMR N/A
- Industry
- FSTR Metal Fabrications
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- FSTR Industrials
- LRMR Health Care
- Exchange
- FSTR Nasdaq
- LRMR Nasdaq
- Market Cap
- FSTR 285.6M
- LRMR 309.8M
- IPO Year
- FSTR N/A
- LRMR N/A
- Fundamental
- Price
- FSTR $25.90
- LRMR $4.74
- Analyst Decision
- FSTR Hold
- LRMR Strong Buy
- Analyst Count
- FSTR 1
- LRMR 7
- Target Price
- FSTR $25.00
- LRMR $16.71
- AVG Volume (30 Days)
- FSTR 27.3K
- LRMR 4.6M
- Earning Date
- FSTR 11-06-2025
- LRMR 10-29-2025
- Dividend Yield
- FSTR N/A
- LRMR N/A
- EPS Growth
- FSTR 395.33
- LRMR N/A
- EPS
- FSTR 3.32
- LRMR N/A
- Revenue
- FSTR $506,999,000.00
- LRMR N/A
- Revenue This Year
- FSTR $3.93
- LRMR N/A
- Revenue Next Year
- FSTR $4.51
- LRMR N/A
- P/E Ratio
- FSTR $7.80
- LRMR N/A
- Revenue Growth
- FSTR N/A
- LRMR N/A
- 52 Week Low
- FSTR $17.16
- LRMR $1.61
- 52 Week High
- FSTR $29.78
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- FSTR 46.48
- LRMR 56.30
- Support Level
- FSTR $26.22
- LRMR $3.10
- Resistance Level
- FSTR $26.90
- LRMR $4.99
- Average True Range (ATR)
- FSTR 0.81
- LRMR 0.52
- MACD
- FSTR -0.25
- LRMR 0.03
- Stochastic Oscillator
- FSTR 4.48
- LRMR 70.48
About FSTR L.B. Foster Company
L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.